ArticleVaccines2024
The Fear of SARS-CoV-2 Infection versus the Perception of COVID-19 Vaccination amongst Older Adults in Urban Areas (CoV-VAC-PL Study): A Polish Community-Based Study.
Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe COVID-19 pandemic not only adversely impacted physical health but also affected older adults' mental health. The first news on COVID-19 vaccination made a major breakthrough to the effect of improving older adults' mood, notwithstanding the fact that vaccinated individuals in this age group accounted only for 40.6% of the overall vaccination rollout in Poland. This study was aimed at assessing the level of anxiety regarding COVID-19 amongst older adults in Poland and assessing the attitude of older adults toward COVID-19 vaccination.
methodsThe study sample encompassed a population of 800 individuals aged 60 years and older randomly picked up from a representative sample of all the residents in 16 voivodeship cities (50 individuals from each of the cities). The research method used in this study was a diagnostic survey, and its technique was based on an author-designed questionnaire and four standardised psychometric scales: the Fear of COVID-19 Scale (FCV-19S), Coronavirus Anxiety Scale (CAS), the Drivers of COVID-19 Vaccination Acceptance Scale (DrVac-COVID-19S), and the Scale to Measure the Perception of SARS-CoV-2 Vaccines Acceptance (the VAC-COVID-19 Scale).
resultsThe degree of fear of SARS-CoV-2 among seniors equalled 1.03 ± 1.95 in terms of the CAS and 15.61 ± 5.75 in terms of the FCV-19S. Attitudes towards COVID-19 vaccination have proven positive (DrVac-COVID-19S-61.23 ± 12.35; VAC-COVID-19-44.31 ± 7.20). Females scored higher than males to the extent of the scales under consideration. The older the respondents were, the higher the scale score. A group of individuals with higher educational status was characterized by substantially higher scores covering the Knowledge subscale (
conclusionsA subjective fear of COVID-19 was measured to be low or moderate within the group under study depending on the scale under consideration, proving declining trends as compared to the results arising from previously conducted studies. Seniors have more often had positive attitudes toward COVID-19 vaccination. The relationship between all of the sociodemographic features under consideration and the feeling of COVID-19 anxiety and between educational status, place of residence, SARS-CoV-2 contraction, COVID-19 vaccination, and the overall attitude toward COVID-19 vaccination indicator was proven to be statistically significant (depending on the scale under consideration). Furthermore, the correlation between the overall results arising from the standardised psychometric scales applied to this study was indicated to be statistically significant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.